Literature DB >> 11477732

Sputum processing for evaluation of inflammatory mediators.

J S Kim1, G H Hackley, K Okamoto, B K Rubin.   

Abstract

Neutrophil-dominated inflammation is prominent in the cystic fibrosis (CF) and chronic bronchitis (CB) airways. We assessed the degree of airway inflammation by measuring the sputum concentrations of interleukin (IL)-8, myeloperoxidase (MPO), and deoxyribonucleic acid (DNA). We determined the relationship among the concentrations of these mediators and investigated methodological problems that may be responsible for reported variability in measurements. Sputa obtained from 31 patients were solubilized with phosphate-buffered saline, dithiothreitol (DTT) (0.1% or 1%), or dornase alfa (0.2 mg/mL). The sputum concentration of IL-8 and MPO was measured by enzyme-linked immunosorbent assay (ELISA), and DNA was measured using microfluorimetry. There was a significant relationship among sputum IL-8, MPO, and DNA. For MPO (means +/- SD), CF was 1,392 +/- 771 vs. CB at 75 +/- 65 mcg/mL; P < 0.0001. For IL-8: CF was 239 +/- 154 vs. CB at 121 +/- 108 ng/mL; P = 0.0002. For DNA, CF was 1.707 +/- 1.25 vs. CB at 0.184 +/- 0.272 mg/mL; P < 0.0001. The MPO concentration in CF sputum was approximately double after in vitro treatment with dornase alfa (P < 0.0001). There is a greater concentration of IL-8, MPO, and DNA in CF than in CB sputa. There is a significant relationship among these inflammatory markers in sputum. DNA polymers bind myeloperoxidase in the sputum, and we speculate that treatment with dornase alfa may remove a source of MPO inhibition. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11477732     DOI: 10.1002/ppul.1101

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Serine proteases degrade airway mucins in cystic fibrosis.

Authors:  Markus O Henke; Gerrit John; Christina Rheineck; Shashi Chillappagari; Lutz Naehrlich; Bruce K Rubin
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

2.  Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Authors:  Vihas T Vasu; Sharon J de Cruz; Jessica S Houghton; Keri A Hayakawa; Brian M Morrissey; Carroll E Cross; Jason P Eiserich
Journal:  Free Radic Res       Date:  2010-10-18

3.  Optical biosensing of markers of mucosal inflammation.

Authors:  Obdulia Covarrubias-Zambrano; Massoud Motamedi; Bill T Ameredes; Bing Tian; William J Calhoun; Yingxin Zhao; Allan R Brasier; Madumali Kalubowilage; Aruni P Malalasekera; Asanka S Yapa; Hongwang Wang; Christopher T Culbertson; Deryl L Troyer; Stefan H Bossmann
Journal:  Nanomedicine       Date:  2021-11-04       Impact factor: 6.096

4.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

Review 5.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

6.  Mucin promotes rapid surface motility in Pseudomonas aeruginosa.

Authors:  Amy T Y Yeung; Alicia Parayno; Robert E W Hancock
Journal:  mBio       Date:  2012-05-01       Impact factor: 7.867

Review 7.  Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.

Authors:  Noora Louhelainen; Marjukka Myllärniemi; Irfan Rahman; Vuokko L Kinnula
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.